Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Public and Occupational Health, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
Netherlands Institute for Health Services Research - Nivel, Utrecht, The Netherlands.
J Adv Nurs. 2022 Sep;78(9):2884-2893. doi: 10.1111/jan.15223. Epub 2022 Mar 21.
In hospital settings, decisions about potentially life-prolonging treatments are often made in a dialogue between a patient and their physician, with a focus on active treatment. Nurses can have a valuable contribution in this process, but it seems they are not always involved. Our aim was to explore how hospital nurses perceive their current role and preferred role in shared decision-making about potentially life-prolonging treatment in patients in the last phase of life.
Cross-sectional quantitative study conducted in the Netherlands in April and May 2019.
An online survey, using a questionnaire consisting of 12 statements on nurses' opinion about supporting patients in decisions about potentially life-prolonging treatments, and 13 statements on nurses' actual involvement in these decisions.
In total 179 hospital nurses from multiple institutions who care for adult patients in the last phase of life responded. Nurses agreed that they should have a role in shared decision-making about potentially life-prolonging treatments, indicating greatest agreement with 'It is my task to speak up for my patient' and 'It is important that my role in supporting patients is clear'. However, nurses also said that in practice they were often not involved in shared decision-making, with least involvement in 'active participation in communication about treatment decisions' and 'supporting a patient with the decision'.
There is a discrepancy between nurses' preferred role in decision-making about potentially life-prolonging treatment and their actual role. More effort is needed to increase nurses' involvement.
Nurses' contribution to decision-making is increasingly considered to be valuable by the nurses themselves, physicians and patients, though involvement is still not common. Future research should focus on strategies, such as training programs, that empower nurses to take an active role in decision-making.
在医院环境中,关于可能延长生命的治疗方法的决策通常是在患者与医生之间进行对话做出的,重点是积极治疗。护士在这个过程中可以做出有价值的贡献,但他们似乎并未始终参与其中。我们的目的是探讨医院护士如何看待自己在生命末期患者潜在延长生命治疗方案的共同决策中的当前角色和偏好角色。
2019 年 4 月至 5 月在荷兰进行的横断面定量研究。
采用在线问卷调查,问卷包括 12 个关于护士对支持患者做出潜在延长生命治疗决策的意见的陈述,以及 13 个关于护士实际参与这些决策的陈述。
共有来自多家机构、照顾生命末期成年患者的 179 名医院护士做出回应。护士们一致认为他们应该在潜在延长生命的治疗方案的共同决策中发挥作用,最认同“为患者发声是我的任务”和“明确我在支持患者方面的角色很重要”这两个观点。然而,护士们也表示,实际上他们经常不参与共同决策,最不参与的是“积极参与治疗决策的沟通”和“支持患者做出决策”。
护士在潜在延长生命的治疗方案决策中的偏好角色与其实际角色之间存在差异。需要做出更多努力来增加护士的参与度。
护士对潜在延长生命的治疗决策的贡献越来越被护士、医生和患者所认可,尽管参与度仍然不高。未来的研究应侧重于策略,例如培训计划,以增强护士在决策中的积极作用。